Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
Daniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Cancers
|
May 28, 2020
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
Riccardo Giampieri, Pina Ziranu, Bruno Daniele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Elisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
Tumori
|
October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement
Stefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2025
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer
Patricia Gomez-Rosas, Magdolna Nagy, Henry M H Spronk, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 13, 2023
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort
Cristina Verzeroli, Cinzia Giaccherini, Laura Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Cancers
|
September 28, 2023
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
Patricia Gomez-Rosas, Cinzia Giaccherini, Laura Russo, et al.
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
Daniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
Cancers
|
May 28, 2020
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
Riccardo Giampieri, Pina Ziranu, Bruno Daniele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 9, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin
Elisa Fontana, Jeff Meyers, Alberto Sobrero, et al.
Tumori
|
October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statement
Stefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Journal of Thrombosis and Haemostasis : JTH
|
March 8, 2025
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer
Patricia Gomez-Rosas, Magdolna Nagy, Henry M H Spronk, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 13, 2023
Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort
Cristina Verzeroli, Cinzia Giaccherini, Laura Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
Timothy J Iveson, Alberto F Sobrero, Takayuki Yoshino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2021
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
Stefano Cascinu, Rossana Berardi, Roberto Bianco, et al.
Cancers
|
September 28, 2023
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients
Patricia Gomez-Rosas, Cinzia Giaccherini, Laura Russo, et al.
The New England Journal of Medicine
|
March 29, 2018
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto F Sobrero, Anthony F Shields, et al.
Page
of 18